Hereditary Hemochromatosis Clinical Trial
Official title:
Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis
Verified date | February 2007 |
Source | San Filippo Neri General Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | Italy: Ministry of Health |
Study type | Interventional |
The purpose of study is to determine the best and durable choice of treatment between phlebotomy and eritrocytoapheresis in the medium- and long-term clinical management of HH
Status | Completed |
Enrollment | 25 |
Est. completion date | December 2006 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Patiens newly diagnosed having Hereditary Hemochromatosis Exclusion Criteria: - Age < 18 yrs. - Not obese (BMI <30) - Not consuming alchol beverages, - Not affected by systemic diseases and known hepatic viruses |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Italy | Department of Transfusion Medicine-San Filippo Neri General Hospital | Rome |
Lead Sponsor | Collaborator |
---|---|
San Filippo Neri General Hospital |
Italy,
Pietrangelo A. Hereditary hemochromatosis--a new look at an old disease. N Engl J Med. 2004 Jun 3;350(23):2383-97. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To prospectively determine the best choice of tretment in HH | |||
Primary | To evaluate the global outcome according to treatment choice | |||
Secondary | To evaluate the outcome of specific clinical features according to treatment choice |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03395704 -
A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis
|
Phase 2 | |
Unknown status |
NCT01398644 -
Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients
|
Phase 3 | |
Terminated |
NCT05238207 -
A Study to Evaluate BBI-001 in Hereditary Haemochromatosis (HH) Patients and Iron Deficient Volunteers
|
Phase 1 | |
Completed |
NCT04202965 -
PTG-300 in Subjects With Hereditary Hemochromatosis
|
Phase 2 | |
Enrolling by invitation |
NCT05742035 -
Quality and Biologic Characteristics of Red Blood Concentrates Obtained From Individuals With Elevated Ferritin.
|
N/A | |
Terminated |
NCT03203850 -
Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH)
|
Phase 2 | |
Completed |
NCT00068159 -
Cardiac Function in Patients With Hereditary Hemochromatosis
|
||
Completed |
NCT00395629 -
Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis
|
Phase 1/Phase 2 |